Cotización TNF Pharmaceuticals - TNFA

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Último Precio

1.1639

Postura de Compra

1.15

Postura de Venta

1.18

Volume Operado de la Acción

30,362

1.14 Rango del Día 1.2277

1.05 Rango de 52 semanas 2.16

Precio Anterior

1.25

Precio de Apertura

1.21

Hora

1.15

Última hora de negociación

10:06:21

Volumen promedio (3 m)

103,055

Volumen financiero

US$ 35,599

Precio Promedio Ponderado

1.1725

TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs

Fully funded study to evaluate Wegovy and Ozempic patients at risk for increased inflammation associated with sarcopenic muscle deterioration Collaboration partner to use AI and machine learning...

TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference

Based on successful Phase 2a data, Company set to initiate Phase 2b sarcopenia study in early 2025; currently securing centers of excellence to begin enrollment First oral TNF-α inhibitor, if...

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form ARS - Annual Report to Security Holders

Form DEF 14A - Other definitive proxy statements

Form 8-K - Current report

TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market

Prevail Partners, LLC investment priced at more than a 40% premium to market Prevail InfoWorks, Inc. to act as Clinical Research Organization partner; global full service CRO with hundreds of...

Form 8-K - Current report

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-0.2061	-15.0437956204	1.37	1.3845	1.14	77050	1.27911172	CS
4	0.0439	3.91964285714	1.12	1.64	1.05	249832	1.40284212	CS
12	-0.2461	-17.4539007092	1.41	1.95	1.05	103055	1.41261209	CS
26	-0.8361	-41.805	2	2.16	1.05	78312	1.53103322	CS
52	-0.8361	-41.805	2	2.16	1.05	78312	1.53103322	CS
156	-0.8361	-41.805	2	2.16	1.05	78312	1.53103322	CS
260	-0.8361	-41.805	2	2.16	1.05	78312	1.53103322	CS

TNFA - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de TNF Pharmaceuticals?

El precio actual de las acciones de TNF Pharmaceuticals es US$ 1.1639

¿Cuál es el rango de negociación de 1 año para el precio de las acciones de TNF Pharmaceuticals?

TNF Pharmaceuticals ha negociado en un rango de US$ 1.05 a US$ 2.16 durante el último año

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
WATTEnergous Corporation	US$ 1.66 (303.70%)	147.46M
NXUNXU Inc	US$ 0.9479 (289.44%)	283.29M
INTZIntrusion Inc	US$ 5.60 (159.26%)	101.64M
CYNCYNGN Inc	US$ 1.36 (116.59%)	27.18M
VINCVincerx Inc	US$ 0.3925 (102.32%)	258.7M
ABPAbpro Holdings Inc	US$ 2.3076 (-48.61%)	815.51k
TRAWTraws Pharma Inc	US$ 8.2234 (-38.72%)	769.8k
LITMSnow Lake Resources Ltd	US$ 1.185 (-25.94%)	38.83M
BITSGlobal X Blockchain and Bitcoin Stratagy ETF	US$ 66.34 (-25.01%)	7.08k
TOIIWOncology Institute Inc	US$ 0.0084 (-22.94%)	75.47k
NXUNXU Inc	US$ 0.9483 (289.61%)	283.3M
VINCVincerx Inc	US$ 0.3922 (102.16%)	258.71M
WATTEnergous Corporation	US$ 1.65 (301.26%)	147.47M
XTIAXTI Aerospace Inc	US$ 0.0401 (1.52%)	145.31M
INTZIntrusion Inc	US$ 5.5932 (158.94%)	101.64M